Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus vaccine H5N2 intranasal - BioDiem

Drug Profile

Influenza A virus vaccine H5N2 intranasal - BioDiem

Alternative Names: GPO Avian Flu Vaccine; GPO H5N2 PLAIV; Intranasal H5N2 vaccine - Institute of Experimental Medicine of the Russian Academy of Medical Sciences/Biodiem; LAIV H5N2 pandemic vaccine; LAIV H5N2/A/Len/17; Pandemic LAIV H5N2

Latest Information Update: 10 Mar 2016

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Institute of Experimental Medicine of the Russian Academy of Medical Sciences
  • Class Influenza A vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 01 Aug 2011 BioDiem regains rights to LAIV technology
  • 24 Dec 2009 BioDiem re-acquires LAIV technology in Japan from Nobilon
  • 05 Dec 2008 Safety and immunogenicity data from a phase II trial in in Influenza A virus H5N2 subtype released by BioDiem
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top